Vaccine adjuvant discovery program
Award Notice Posted
- Solicitation number
- BAA-DAIT-75N93022R00022
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Institut De Formulation DES Vaccins (Ch) SA
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93024C00021 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Switzerland
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice is for a cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency under the Department of Health and Human Services, to INSTITUT DE FORMULATION DES VACCINS (CH) SA for the VACCINE ADJUVANT DISCOVERY PROGRAM. The contract, valued at $9,189,961.00, was awarded on September 18, 2024 and involves the discovery and development of vaccine adjuvants, which are substances used to enhance the immune response to a vaccine.
Notice text
This is not fixed-priced. This is a cost-reimbursement contract.
Awarded contract 75N93024C00021 to INSTITUT DE FORMULATION DES VACCINS (CH) SA for 9189961.00 on 2024-09-18.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| Vaccine adjuvant discovery program | Award Notice | |
| This notice | Award Notice | |
| Vaccine adjuvant discovery program | Solicitation | |
| Vaccine adjuvant discovery program | Pre-Solicitation |
6 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity